General Information of the Compound
| Compound ID |
CP0575202
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[(1S,3S,4S,7S,9S)-9-(3-benzamidophenyl)-3,9-dimethyl-2,5,8-trioxa-10-azatricyclo[5.2.1.04,10]decan-3-yl]phenyl]-3-methoxybenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H33N3O6
|
||||||||||||||||||
| Molecular Weight |
591.664
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc(c1)C(=O)Nc1cccc(c1)[C@]1(C)O[C@@H]2N3[C@H](CO[C@@H]13)O[C@@]2(C)c1cccc(NC(=O)c2ccccc2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H33N3O6/c1-34(24-13-8-16-27(19-24)37-31(40)23-12-7-17-28(18-23)41-3)32-38-29(21-42-32)43-35(2,33(38)44-34)25-14-9-15-26(20-25)36-30(39)22-10-5-4-6-11-22/h4-20,29,32-33H,21H2,1-3H3,(H,36,39)(H,37,40)/t29-,32-,33-,34-,35-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KWZATPHLNBHNFW-VYKSXFOXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1